SELECTAN ORAL 23 mg/ml solution for use in drinking water for pigs

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

有効成分:

Florfenicol

から入手可能:

Laboratorios Hipra S.A.

ATCコード:

QJ01BA90

INN（国際名）:

Florfenicol

投薬量:

23 milligram(s)/millilitre

医薬品形態:

Solution for use in drinking water

処方タイプ:

POM: Prescription Only Medicine as defined in relevant national legislation

治療群:

Pigs

治療領域:

florfenicol

適応症:

Antibacterial

認証ステータス:

Authorised

承認日:

2011-04-15

製品の特徴

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
SELECTAN ORAL 23 mg/ml solution for use in drinking water for pigs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
EACH ML CONTAINS:
ACTIVE SUBSTANCE:
Florfenicol
……………………………………………………………………………
23 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Solution for use in drinking water.
A slightly yellowish and clear solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs:
Treatment
and metaphylaxis at
the group level
where clinical
signs are present
of
swine respiratory disease
associated with_ Actinobacillus pleuropneumoniae_ and_ Pasteurella
multocida_ susceptible to florfenicol.
The presence of the disease should be established in the herd before
initiating preventive treatment_._
4.3 CONTRAINDICATIONS
Do not use in boars intended for breeding purposes.
Do not use in cases of known hypersensitivity to the active substance
or to the excipient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The treated pigs should be placed under
special
observation.
On each of
the five days of
treatment,
unmedicated
drinking water should not be given until the full daily amount of
medicated drinking water has been ingested by pigs.
If there are no signs of improvement after three days of treatment,
the diagnosis should be reviewed and, if necessary,
the treatment changed.
Animals showing a decreased water intake and/or a poor general
condition should be treated by the parenteral route.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_